Anu Chawla/LinkedIn
Jun 29, 2026, 11:44
Anu Chawla: PICSI in Focus, What the HABSelect Trial Revealed?
Anu Chawla, Chairperson at Federation of obstetrics and Gynaecological Societies of India, shared a post on LinkedIn:
- The HABSelect Trial is the largest randomised study evaluating PICSI.
- It included 2,722 couples across 16 UK fertility centres.
- PICSI did not significantly improve overall live birth rates compared with standard ICSI.
- PICSI was associated with a lower miscarriage rate (14% vs 22%), representing approximately a 38% relative reduction.
- Current international guidelines do not recommend routine PICSI for every patient, but selected individuals may benefit.
- Treatment decisions should always be personalised following discussion with a fertility specialist.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 18, 2026, 18:26Ritu Anand: We’ve Been Talking about Her Fertility – It’s Time to Talk about His
-
Nov 18, 2026, 18:20Sean Lauber: Is It Safe to Thaw and Rebiopsy an Embryo?
-
Nov 18, 2026, 18:14Arsiak Vartenian: 8 Years of Answering “Do You Have Kids?” Is a Long Time
-
Nov 18, 2026, 18:09Esther Eleboh: When the Same Protocol Produces Completely Different Embryo Outcomes
-
Nov 18, 2026, 18:05Resa Nabor: Having PCOS Doesn’t Make You Less of a Woman or Less Deserving of Love
-
Nov 18, 2026, 17:47Diana Kayal: Co-Chairing the 3rd International Conference on Gynecology and Women’s Health
-
Nov 18, 2026, 17:44Karthik Raj: Oocyte Quality Is Not Determined at Retrieval Alone
-
Nov 18, 2026, 17:41Tazeen Farhan: 10 Small Lifestyle Changes to Support Reproductive Health
-
Nov 18, 2026, 17:35Chanju Jung: Nature Paper Explores Base Editing in Human Embryos
